» Articles » PMID: 32075918

Assessing Aneuploidy with Repetitive Element Sequencing

Abstract

We report a sensitive PCR-based assay called Repetitive Element AneupLoidy Sequencing System (RealSeqS) that can detect aneuploidy in samples containing as little as 3 pg of DNA. Using a single primer pair, we amplified ∼350,000 amplicons distributed throughout the genome. Aneuploidy was detected in 49% of liquid biopsies from a total of 883 nonmetastatic, clinically detected cancers of the colorectum, esophagus, liver, lung, ovary, pancreas, breast, or stomach. Combining aneuploidy with somatic mutation detection and eight standard protein biomarkers yielded a median sensitivity of 80% in these eight cancer types, while only 1% of 812 healthy controls scored positive.

Citing Articles

Genomic and fragmentomic landscapes of cell-free DNA for early cancer detection.

Bruhm D, Vulpescu N, Foda Z, Phallen J, Scharpf R, Velculescu V Nat Rev Cancer. 2025; .

PMID: 40038442 DOI: 10.1038/s41568-025-00795-x.


A perspective review on the systematic implementation of ctDNA in phase I clinical trial drug development.

Guigal-Stephan N, Lockhart B, Moser T, Heitzer E J Exp Clin Cancer Res. 2025; 44(1):79.

PMID: 40022112 PMC: 11871688. DOI: 10.1186/s13046-025-03328-4.


Liquid Biopsy for Spinal Tumors: On the Frontiers of Clinical Application.

Tan S, Bettegowda C, Yip S, Sahgal A, Rhines L, Reynolds J Global Spine J. 2025; 15(1_suppl):16S-28S.

PMID: 39801114 PMC: 11726521. DOI: 10.1177/21925682231222012.


Shifting the Cancer Screening Paradigm: Developing a Multi-Biomarker Class Approach to Multi-Cancer Early Detection Testing.

Kisiel J, Ebbert J, Taylor W, Marinac C, Choudhry O, Rego S Life (Basel). 2024; 14(8).

PMID: 39202669 PMC: 11355654. DOI: 10.3390/life14080925.


The changing face of circulating tumor DNA (ctDNA) profiling: Factors that shape the landscape of methodologies, technologies, and commercialization.

Bronkhorst A, Holdenrieder S Med Genet. 2024; 35(4):201-235.

PMID: 38835739 PMC: 11006350. DOI: 10.1515/medgen-2023-2065.


References
1.
Gromminger S, Yagmur E, Erkan S, Nagy S, Schock U, Bonnet J . Fetal Aneuploidy Detection by Cell-Free DNA Sequencing for Multiple Pregnancies and Quality Issues with Vanishing Twins. J Clin Med. 2015; 3(3):679-92. PMC: 4449645. DOI: 10.3390/jcm3030679. View

2.
Deleye L, Dheedene A, De Coninck D, Sante T, Christodoulou C, Heindryckx B . Shallow whole genome sequencing is well suited for the detection of chromosomal aberrations in human blastocysts. Fertil Steril. 2015; 104(5):1276-85.e1. DOI: 10.1016/j.fertnstert.2015.07.1144. View

3.
Underhill H, Kitzman J, Hellwig S, Welker N, Daza R, Baker D . Fragment Length of Circulating Tumor DNA. PLoS Genet. 2016; 12(7):e1006162. PMC: 4948782. DOI: 10.1371/journal.pgen.1006162. View

4.
Cohen J, Li L, Wang Y, Thoburn C, Afsari B, Danilova L . Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science. 2018; 359(6378):926-930. PMC: 6080308. DOI: 10.1126/science.aar3247. View

5.
Suzumori N, Ebara T, Yamada T, Samura O, Yotsumoto J, Nishiyama M . Fetal cell-free DNA fraction in maternal plasma is affected by fetal trisomy. J Hum Genet. 2016; 61(7):647-52. DOI: 10.1038/jhg.2016.25. View